Richard Urbanowicz

Lecturer in Infection Immunology

University of Liverpool

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Richard Urbanowicz is a Lecturer in Infection Immunology at the University of Liverpool, UK. His research areas focus on the immune responses to viral infections, specifically hepatitis C, influenza, and COVID-19. Recent publications include studies on glycoprotein interactions in Ebola virus entry, the inhibition of influenza by seaweed extracts, and vaccine development strategies targeting hepatitis C. He is actively involved in understanding the role of immune responses in viral pathogenesis and vaccine efficacy.

Articles (15)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (18)

Udo Hetzel

University of Zurich

SWITZERLAND

Richard Urbanowicz

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

&lt;i&gt;Wisteria floribunda&lt;/i&gt; agglutinin enhances &lt;i&gt;Zaire ebolavirus&lt;/i&gt; entry through interactions at specific &lt;i&gt;N&lt;/i&gt;-linked glycosylation sites on the virus glycoprotein complex.

Recombinant H77C gpE1/gpE2 heterodimer elicits superior HCV cross-neutralisation than H77C gpE2 alone.

Phlorotannin-Rich Ascophyllum nodosum Seaweed Extract Inhibits Influenza Infection

Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virus

Annual Meeting of the Canadian Association for the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CanHepC), the Canadian Association of Hepatology Nurses (CAHN), and the Canadian NASH Network 2022 Abstracts.

Optimization of the pseudoparticle system for standardized assessments of neutralizing antibodies against hepatitis C virus

An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development

HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19

Inflammasome Contribution to the Activation of Th1, Th2, and Th17 Immune Responses

Long Term Immune Response Produced by the SputnikV Vaccine

The Distribution of Puumala orthohantavirus Genome Variants Correlates with the Regional Landscapes in the Trans-Kama Area of the Republic of Tatarstan

Challenges on the development of a pseudotyping assay for Zika glycoproteins

Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection

Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19

The Relationship of the Mechanisms of the Pathogenesis of Multiple Sclerosis and the Expression of Endogenous Retroviruses

Collaborators (18)

Udo Hetzel

Georgine Cua

Sofia Bartlett

Brian Pierce

Richard Molenkamp

Aine McKnight

Sarah Haylock-Jacobs

Francesco Talotta

Benjamin Ollivere

Lee Howes

Jessica Nightingale

Alexander Tarr

Adam J. Gehring

Michelle Amantea Sugimoto

Muhammad Atif Zahoor

George Joy

Angelo Raggioli

Marit J. van Gils

Make your next move.

<i>Wisteria floribunda</i> agglutinin enhances <i>Zaire ebolavirus</i> entry through interactions at specific <i>N</i>-linked glycosylation sites on the virus glycoprotein complex.